ArticlePediatric blood & cancer2010

Initial testing (stage 1) of the multi-targeted kinase inhibitor sorafenib by the pediatric preclinical testing program.

Stephen T Keir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.